Episode Summary
Executive Summary: Mark Cuban argues healthcare is fundamentally broken because it’s opaque, intermediated by PBMs and insurers, and priced without transparency. He describes Cost Plus Drugs and Cost Plus Wholesale as proof that publishing costs and contracts can slash prices, while urging businesses to self-insure smarter, hire healthcare CFOs, and expose claims data. He also connects the same entrepreneurial mindset to education and American innovation.
Main Topics: Healthcare transparency as the core fix (Priority: 5/5): Cuban says healthcare’s biggest problem is opacity: patients and employers don’t know what they’re paying for, enabling inflated pricing and middlemen margins. Cost Plus Drugs publishes costs, markups, and price lists to force competition. Cost Plus Drugs and wholesale expansion (Priority: 5/5): He explains how Cost Plus Drugs sells generics and some branded/biosimilar drugs at published cost-plus pricing, and how Cost Plus Wholesale extends that model to hospitals and other buyers who couldn’t access retail pricing. PBMs, insurers, and middleman economics (Priority: 5/5): Cuban criticizes pharmacy benefit managers and large insurers for dominating the market, keeping contracts opaque, steering formularies, and extracting rebates that ultimately burden sick and elderly patients. Employer self-insurance and healthcare CFOs (Priority: 4/5): He recommends CEOs of self-insured companies treat healthcare as a core business function: cut unnecessary benefits brokers, demand claims data, negotiate directly with providers, and hire a dedicated healthcare CFO. Direct contracting and cash pricing (Priority: 4/5): Cuban argues employers can often pay much less by bypassing insurance for routine care, using cash prices, direct contracts, and transparent third-party administrators while keeping catastrophic insurance for rare high-cost events. Independent pharmacies and limited government intervention (Priority: 3/5): He says legislation should mainly protect independent pharmacies from unfair PBM practices, while broader reform is better driven by market pressure, transparency, and large employers walking away from legacy systems. Broader American entrepreneurship and education (Priority: 3/5): The conversation expands to Cuban’s view that America should celebrate entrepreneurship more and that education is also ripe for disruption because accreditation, bureaucracy, and campus overhead inflate costs without clear value.
Key Arguments: Healthcare prices stay high because the system is opaque; transparency exposes markups and creates immediate downward pressure on prices. Publishing cost, markup, and contract details is itself a sales strategy because buyers can see they are being overcharged. Employers that self-insure often pay more than necessary due to benefits brokers, insurance companies, and PBMs taking cuts without adding commensurate value. Hiring a healthcare CFO can save a mid-sized or large company far more than the role costs by actively managing claims, networks, and contracting. PBMs distort formularies and rebate flows, and the people who end up subsidizing rebates are often the oldest and sickest employees. Direct cash payment and cash contracting can produce dramatically lower prices than insurance-negotiated rates for the same care. Large employers could force industry change if they collectively left the big insurers and PBMs and published their own contracts. Independent pharmacies are being squeezed out by PBM reimbursement and DIR-fee structures, suggesting a need for targeted policy protection. Education suffers from similar inefficiencies and prestige-driven spending, making it another sector suitable for entrepreneurial disruption. Entrepreneurship should be more actively celebrated in the U.S. as central to the American dream and national competitiveness.
Data Points: Cost Plus Drugs catalog size: about 2,450 drugs - Cuban says the site currently lists roughly 2,450 medications and is growing daily. Cost Plus markup: 15% - Published markup on drugs sold through Cost Plus Drugs. Mail-order fee: $10 shipping and pharmacy fee - Additional fee for mail-order purchases from Cost Plus Drugs. Retail fee: $9 pharmacy fee - Fee for retail network purchases at the same price structure. Cost of droxedopa example: $10,000 every three months vs. about $50 a month - Example of a patient price dropping dramatically through Cost Plus pricing. Potential government savings example: $3.6 billion - Cuban cites research comparing Cost Plus pricing to CMS purchasing for three urology drugs. Big insurance negotiated hospital rates: 250% to 275% of Medicare - Typical negotiated network pricing Cuban says employers pay through traditional insurers. Direct contract hospital rates: 80% to 100% of Medicare - Price range he says Cost Plus is negotiating via direct contracting. Employee benefits manager fee: $30 per month per employee - Cuban describes paying this for his companies before cutting the broker out. Savings from cutting employee benefits manager: $2 million - He estimates that removing the benefits manager saved about this much. Hospital cash vs. insurance price example: $475 vs. $2,200 - Example where paying cash with a credit card was far cheaper than the insurance price. Annual family healthcare cost: $26,000 to $29,000 per year - Cuban says this was his self-insured family cost for coverage. Employees/lives covered: about 1,700 employees and roughly 1,000 lives - He references coverage across his companies when discussing self-insurance. Market share: 80% to 90% - Cuban says the three dominant PBMs control this share of the market. Cost Plus share of cash mail-order market: 17% - He says Cost Plus has reached about 17% of the cash mail-order market at that time. Independent pharmacy fill cost: about $12 per script - He says this is roughly what an independent pharmacy spends to fill a prescription. PBM reimbursement to independent pharmacies: 50 cents - Example of how low reimbursement can be under big PBM arrangements. DIR fee loss: $10 to $30 per fill - He says Medicare/Medicare Advantage fills can lose independent pharmacies this amount per prescription. Healthcare CFO compensation: $200,000 to $300,000 - He suggests this level of pay for a specialized healthcare CFO at companies with 100+ employees.
Pivotal Quotes: "You know how much you spend on healthcare, but you have no idea what you're spending it on." — Mark Cuban: Cuban describes the core opacity problem in employer healthcare spending. "Transparency is the best salesperson ever." — Mark Cuban: He explains why Cost Plus Drugs spends nothing on marketing and still grows. "We all can take responsibility for changing the healthcare industry and it's not a complicated industry." — Mark Cuban: Cuban argues employers and buyers can force change by refusing opaque middlemen and publishing contracts.
Implications: Listeners are urged to treat healthcare like a controllable business expense: demand data, compare cash prices, cut unnecessary middlemen, and use direct contracting. If large buyers copy this model, pricing could fall quickly and pressure PBMs/insurers to change.
About The a16z Podcast
The a16z Podcast discusses tech and culture trends, news, and the future – especially as ‘software eats the world’. It features industry experts, business leaders, and other interesting thinkers and voices from around the world. This podcast is produced by Andreessen Horowitz (aka “a16z”), a Silicon Valley-based venture capital firm. Multiple episodes are released every week; visit a16z.com for more details and to sign up for our newsletters and other content as well!